4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-20-000182
Director sold 5,000 shares at an average $266.42 ($1,332,117)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAUMGARTNER ROBERT V Director | 2020-05-21 | Option exercise | +5,000 | $70.35 | $351,750 | 14,221 | D: show line 1 in the form |
| BAUMGARTNER ROBERT V Director | 2020-05-21 | Sale | −1,300 | $265.35 | $344,960 | 12,921 | D: show line 2 in the form |
| BAUMGARTNER ROBERT V Director | 2020-05-21 | Sale | −1,601 | $266.07 | $425,979 | 11,320 | D: show line 3 in the form |
| BAUMGARTNER ROBERT V Director | 2020-05-21 | Sale | −1,974 | $267.32 | $527,685 | 9,346 | D: show line 4 in the form |
| BAUMGARTNER ROBERT V Director | 2020-05-21 | Sale | −125 | $267.94 | $33,493 | 9,221 | D: show line 5 in the form |
| Open-market sales · 5,000 sh · avg $266.42 · $1,332,117 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAUMGARTNER ROBERT V Director | 2020-05-21 | Option exercise · Stock Options (right to Buy) | −5,000 | 0 | D: show line 6 in the form |
Loading xslF345X03/edgar.xml…